Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database.
Saved in:
| Title: | Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database. |
|---|---|
| Authors: | Helland T; Hormone Laboratory, Haukeland University Hospital, 5020, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Hagen KB; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Breast and Endocrine Surgery, Haukeland University Hospital, Bergen, Norway., Haugstøyl ME; Hormone Laboratory, Haukeland University Hospital, 5020, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Kvaløy JT; Department of Mathematics and Natural Science, University of Stavanger, Stavanger, Norway.; Department of Research, Stavanger University Hospital, Stavanger, Norway., Lunde S; Department of Breast and Endocrine Surgery, Stavanger University Hospital, Stavanger, Norway., Lode K; Department of Research, Stavanger University Hospital, Stavanger, Norway., Lind RA; Department of Clinical Science, University of Bergen, Bergen, Norway., Gripsrud BH; Department of Caring and Ethics, Faculty of Health Sciences, University of Stavanger, Stavanger, Norway., Jonsdottir K; Department of Breast and Endocrine Surgery, Stavanger University Hospital, Stavanger, Norway.; Department of Research, Stavanger University Hospital, Stavanger, Norway., Gjerde J; Hormone Laboratory, Haukeland University Hospital, 5020, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Bifulco E; Department of Clinical Science, University of Bergen, Bergen, Norway.; Core Facility for Metabolomics, University of Bergen, Bergen, Norway., Hustad S; Department of Clinical Science, University of Bergen, Bergen, Norway.; Core Facility for Metabolomics, University of Bergen, Bergen, Norway., Jonassen J; Department of Breast and Endocrine Surgery, Stavanger University Hospital, Stavanger, Norway., Aas T; Department of Breast and Endocrine Surgery, Haukeland University Hospital, Bergen, Norway., Lende TH; Department of Breast and Endocrine Surgery, Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Lien EA; Hormone Laboratory, Haukeland University Hospital, 5020, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Janssen EAM; Department of Mathematics and Natural Science, University of Stavanger, Stavanger, Norway.; Department of Pathology, Stavanger University Hospital, Stavanger, Norway., Søiland H; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Breast and Endocrine Surgery, Stavanger University Hospital, Stavanger, Norway., Mellgren G; Hormone Laboratory, Haukeland University Hospital, 5020, Bergen, Norway. gunnar.mellgren@uib.no.; Department of Clinical Science, University of Bergen, Bergen, Norway. gunnar.mellgren@uib.no. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Aug; Vol. 177 (1), pp. 185-195. Date of Electronic Publication: 2019 May 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-019-05294-w |
